Changes observed in radionuclide bone scans during and after teriparatide treatment for osteoporosis

被引：0
|
作者：
Amelia E. B. Moore
Glen M. Blake
Kathleen A. Taylor
Valerie A. Ruff
Asad E. Rana
Xiaohai Wan
Ignac Fogelman
机构：
[1] King’s College London School of Medicine,Department of Nuclear Medicine, Borough Wing; Guy’s Hospital
[2] Eli Lilly and Company and/or one of its subsidiaries,undefined
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2012年 / 39卷
关键词：
Teriparatide; Tc-MDP bone scan; Bone turnover markers; Bone remodelling; Osteoporosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：326 / 336
页数：10
相关论文
共 50 条
  • [1] Changes observed in radionuclide bone scans during and after teriparatide treatment for osteoporosis
    Moore, Amelia E. B.
    Blake, Glen M.
    Taylor, Kathleen A.
    Ruff, Valerie A.
    Rana, Asad E.
    Wan, Xiaohai
    Fogelman, Ignac
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 (02) : 326 - 336
  • [2] Bone: Teriparatide in sequential osteoporosis treatment
    Wilson C.
    Nature Reviews Endocrinology, 2009, 5 (4) : 182 - 182
  • [3] CHANGES IN BONE TURNOVER MARKERS CAN PREDICT THE RESPONSE IN BONE MINERAL DENSITY DURING TERIPARATIDE TREATMENT IN OSTEOPOROSIS
    Moro-Alvarez, M.
    Cogolludo-Perez, F.
    Andrade, M.
    de la Piedra, C.
    Diaz-Curiel, M.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 : 77 - 77
  • [4] A Bone Histomorphometric Analysis of Hypophosphatasia-related Osteoporosis after Teriparatide Treatment
    Mizuno, Hiroki
    Sawa, Naoki
    Sekine, Akinari
    Inoue, Noriko
    Oba, Yuki
    Ikuma, Daisuke
    Yamanouchi, Masayuki
    Hasegawa, Eiko
    Suwabe, Tatsuya
    Suzuki, Hisanori
    Hoshino, Junichi
    Ubara, Yoshifumi
    INTERNAL MEDICINE, 2023, 62 (01) : 75 - 79
  • [5] Changes in Bone Quality after One Year of Teriparatide Treatment
    Lima, Florence
    Rao, Madhumathi
    JOURNAL OF BONE AND MINERAL RESEARCH, 2020, 35 : 59 - 59
  • [6] Changes in bone mineral density and bone turnover markers during treatment with teriparatide in pregnancy- and lactation-associated osteoporosis
    Hong, Namki
    Kim, Jo Eun
    Lee, Su Jin
    Kim, Se Hwa
    Rhee, Yumie
    CLINICAL ENDOCRINOLOGY, 2018, 88 (05) : 652 - 658
  • [7] Evaluation of BMD Changes in Women with Severe Osteoporosis after Teriparatide Treatment.
    Malavolta, N.
    Buffa, A.
    Vukatana, G.
    Mule, R.
    Frigato, M.
    Migliaccio, S.
    Iolascon, G.
    Resmini, G.
    Borghi, C.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S462 - S462
  • [8] Bone Density After Teriparatide Discontinuation in Premenopausal Idiopathic Osteoporosis
    Cohen, Adi
    Kamanda-Kosseh, Mafo
    Recker, Robert. R.
    Lappe, Joan M.
    Dempster, David W.
    Zhou, Hua
    Cremers, Serge
    Bucovsky, Mariana
    Stubby, Julie
    Shane, Elizabeth
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (11): : 4208 - 4214
  • [9] Hypomagnesemia During Teriparatide Treatment in Osteoporosis: Incidence and Determinants
    Begin, Marie-Josee
    Ste-Marie, Louis-Georges
    Coupal, Louis
    Ethier, Jean
    Rakel, Agnes
    JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 (08) : 1444 - 1449
  • [10] Effects of ibandronate on bone mineral density and microstructure in patients with primary osteoporosis after treatment with teriparatide
    Chiba, Ko
    Okazaki, Narihiro
    Shiraishi, Kazuteru
    Osaki, Makoto
    JOURNAL OF BONE AND MINERAL RESEARCH, 2019, 34 : 163 - 163
12345